Samar Farid

860 total citations
51 papers, 602 citations indexed

About

Samar Farid is a scholar working on Economics and Econometrics, Geriatrics and Gerontology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Samar Farid has authored 51 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 9 papers in Geriatrics and Gerontology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Samar Farid's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Pharmaceutical Practices and Patient Outcomes (9 papers) and Pharmaceutical Economics and Policy (5 papers). Samar Farid is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Pharmaceutical Practices and Patient Outcomes (9 papers) and Pharmaceutical Economics and Policy (5 papers). Samar Farid collaborates with scholars based in Egypt, United Kingdom and Netherlands. Samar Farid's co-authors include Nirmeen A. Sabry, Dalia Dawoud, Ahmed Kamel, Maggie Abbassi, Darrin Baines, Ahmed H. Ali, Manal H. El‐Sayed, Iman Saad Ahmed, Osama Mohamed Ibrahim and Aureliano Paolo Finch and has published in prestigious journals such as Frontiers in Pharmacology, BMJ Open and European Journal of Pharmaceutical Sciences.

In The Last Decade

Samar Farid

46 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samar Farid Egypt 14 131 104 96 80 72 51 602
Farida Islahudin Malaysia 15 105 0.8× 78 0.8× 114 1.2× 72 0.9× 52 0.7× 77 772
Shusen Sun United States 20 223 1.7× 74 0.7× 130 1.4× 141 1.8× 73 1.0× 85 1.4k
Rongsheng Zhao China 12 136 1.0× 75 0.7× 51 0.5× 167 2.1× 33 0.5× 67 756
Anthony P. Morreale United States 18 285 2.2× 103 1.0× 90 0.9× 71 0.9× 138 1.9× 61 1.1k
Pedro Amariles Colombia 17 243 1.9× 51 0.5× 50 0.5× 114 1.4× 57 0.8× 107 772
Fikret Vehbi İzzettin Türkiye 15 233 1.8× 53 0.5× 78 0.8× 49 0.6× 48 0.7× 52 723
Abdulla Shehab United Arab Emirates 18 223 1.7× 62 0.6× 84 0.9× 35 0.4× 150 2.1× 68 1.2k
Ju‐Yeun Lee South Korea 17 280 2.1× 52 0.5× 107 1.1× 99 1.2× 88 1.2× 135 1.2k
Vincent D. Marshall United States 18 91 0.7× 39 0.4× 121 1.3× 46 0.6× 57 0.8× 62 802
Surakit Nathisuwan Thailand 19 108 0.8× 62 0.6× 145 1.5× 18 0.2× 107 1.5× 72 1.2k

Countries citing papers authored by Samar Farid

Since Specialization
Citations

This map shows the geographic impact of Samar Farid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samar Farid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samar Farid more than expected).

Fields of papers citing papers by Samar Farid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samar Farid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samar Farid. The network helps show where Samar Farid may publish in the future.

Co-authorship network of co-authors of Samar Farid

This figure shows the co-authorship network connecting the top 25 collaborators of Samar Farid. A scholar is included among the top collaborators of Samar Farid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samar Farid. Samar Farid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sabry, Nirmeen A., et al.. (2025). Impact of pharmacist led mobile application on medication adherence and efficacy in chronic kidney disease. npj Digital Medicine. 8(1). 325–325.
2.
Farid, Samar, et al.. (2025). Adjuvant nefopam versus standard of care in mechanically ventilated surgical critically ill patients: A randomized, double-blind controlled study. Anaesthesia Critical Care & Pain Medicine. 44(3). 101518–101518.
3.
Salem, Salem, et al.. (2025). The nephroprotective effect of metformin with cisplatin in bladder cancer: randomized clinical trial. International Urology and Nephrology. 57(11). 3611–3624.
4.
Kamel, Ahmed, et al.. (2023). Effect of Metformin on Oxidative Stress and Left Ventricular Geometry in Nondiabetic Heart Failure Patients: A Randomized Controlled Trial. Metabolic Syndrome and Related Disorders. 22(1). 49–58. 5 indexed citations
5.
6.
Kamel, Ahmed, et al.. (2023). COVID-19 vaccine hesitancy in Egypt: a cross-sectional study. The Journal of Infection in Developing Countries. 17(9). 1188–1198. 2 indexed citations
7.
Kamel, Ahmed, Nirmeen A. Sabry, & Samar Farid. (2022). Effect of metformin on left ventricular mass and functional parameters in non-diabetic patients: a meta-analysis of randomized clinical trials. BMC Cardiovascular Disorders. 22(1). 405–405. 15 indexed citations
8.
Roudijk, Bram, et al.. (2022). The Egyptian EQ-5D-5L Extensive Pilot Study: Lessons Learned. PharmacoEconomics. 41(3). 329–338. 1 indexed citations
9.
Sayah, Fatima Al, et al.. (2022). Determinants of Health Preferences Using Data from the Egyptian EQ-5D-5L Valuation Study. Patient. 15(5). 589–598. 6 indexed citations
10.
Kamel, Ahmed, et al.. (2021). Efficacy and safety of azithromycin in Covid‐19 patients: A systematic review and meta‐analysis of randomized clinical trials. Reviews in Medical Virology. 32(1). e2258–e2258. 41 indexed citations
11.
Abbassi, Maggie, et al.. (2021). The EQ-5D-5L Valuation Study in Egypt. PharmacoEconomics. 40(4). 433–447. 22 indexed citations
12.
Farid, Samar, et al.. (2021). The potential hepatoprotective effect of metformin in hepatitis C virus‐infected adolescent patients with beta thalassemia major: Randomised clinical trial. International Journal of Clinical Practice. 75(6). e14104–e14104. 12 indexed citations
13.
Abbassi, Maggie, et al.. (2021). EQ-VT protocol: one-size-fits-all? Challenges and innovative adaptations used in Egypt: a cross-sectional study. BMJ Open. 11(12). e051727–e051727. 2 indexed citations
14.
Sabry, Nirmeen A., et al.. (2020). Combined effect of high-dose vitamin A, vitamin E supplementation, and zinc on adult patients with diabetes: A randomized trial. Journal of Advanced Research. 28. 27–33. 34 indexed citations
15.
Sabry, Nirmeen A., et al.. (2020). Short-term Effects of Alfacalcidol on Hospital Length of Stay in Patients Undergoing Valve Replacement Surgery: A Randomized Clinical Trial. Clinical Therapeutics. 43(1). e1–e18. 7 indexed citations
16.
Sabry, Nirmeen A., Samar Farid, & Dalia Dawoud. (2016). Drug-related problems in cardiac children.. PubMed. 68(2). 89–95. 8 indexed citations
17.
18.
Ali, Ahmed H., et al.. (2014). Clinical study on the therapeutic role of midodrine in non azotemic cirrhotic patients with tense ascites: a double-blind, placebo-controlled, randomized trial.. PubMed. 61(135). 1915–24. 9 indexed citations
19.
Farid, Samar, et al.. (2009). Management of Intraepithelial and Invasive Neoplasia of the Cornea and Conjunctiva: A Long-Term Follow Up. Cornea. 28(9). 986–988. 30 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farida Islahudin Breakdown of academic impact, for papers by Shusen Sun Breakdown of academic impact, for papers by Rongsheng Zhao Breakdown of academic impact, for papers by Anthony P. Morreale Breakdown of academic impact, for papers by Pedro Amariles Breakdown of academic impact, for papers by Fikret Vehbi İzzettin Breakdown of academic impact, for papers by Abdulla Shehab Breakdown of academic impact, for papers by Ju‐Yeun Lee Breakdown of academic impact, for papers by Vincent D. Marshall Breakdown of academic impact, for papers by Surakit Nathisuwan
Rankless by CCL
2026